Literature DB >> 3025652

Determination of the orientation of an integral membrane protein and sites of glycosylation by oligonucleotide-directed mutagenesis: influenza B virus NB glycoprotein lacks a cleavable signal sequence and has an extracellular NH2-terminal region.

M A Williams, R A Lamb.   

Abstract

The membrane orientation of the NB protein of influenza B virus, a small (Mr, approximately 18,000) glycoprotein with a single internal hydrophobic domain, was investigated by biochemical and genetic means. Cell fractionation and protein solubility studies indicate NB is an integral membrane protein, and NB has been shown to be a dimer under nonreducing conditions. Treatment of infected-cell surfaces with proteinase K and endoglycosidase F and immunoprecipitation with a site-specific antibody suggests that the 18-amino-acid NH2-terminal region of NB is exposed at the cell surface. Oligonucleotide-directed mutagenesis to eliminate each of the four potential sites of N-linked glycosylation and expression of the mutant NB proteins in eucaryotic cells suggest that the two sites adjacent to the NH2 terminus are glycosylated. This provides further evidence that NB, which lacks a cleavable NH2-terminal signal sequence, has an exposed NH2 terminus at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025652      PMCID: PMC367213          DOI: 10.1128/mcb.6.12.4317-4328.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Primary structure and transmembrane orientation of the murine anion exchange protein.

Authors:  R R Kopito; H F Lodish
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

2.  Amino-acid sequence of a Ca2+ + Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence.

Authors:  D H MacLennan; C J Brandl; B Korczak; N M Green
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

3.  Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA.

Authors:  G E Shull; A Schwartz; J B Lingrel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

4.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

5.  Studies on the formation of the influenza virus envelope.

Authors:  A J Hay
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

6.  Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor.

Authors:  S W Hiebert; R G Paterson; R A Lamb
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

7.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

8.  Multiple mechanisms of protein insertion into and across membranes.

Authors:  W T Wickner; H F Lodish
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

9.  A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface.

Authors:  C E Machamer; R Z Florkiewicz; J K Rose
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

10.  Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus.

Authors:  C D Richardson; A Berkovich; S Rozenblatt; W J Bellini
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

View more
  40 in total

1.  Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature.

Authors:  J A McCullers; G C Wang; S He; R G Webster
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus.

Authors:  P J Gallagher; J M Henneberry; J F Sambrook; M J Gething
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus.

Authors:  X Wu; S Y Chen; H Iwata; R W Compans; P Roy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Reptilian reovirus utilizes a small type III protein with an external myristylated amino terminus to mediate cell-cell fusion.

Authors:  Jennifer A Corcoran; Roy Duncan
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Polylactosaminoglycan modification of a small integral membrane glycoprotein, influenza B virus NB.

Authors:  M A Williams; R A Lamb
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

8.  Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein.

Authors:  Shinji Watanabe; Masaki Imai; Yoshiro Ohara; Takato Odagiri
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.

Authors:  S Shibata; F Yamamoto-Goshima; K Maeno; T Hanaichi; Y Fujita; K Nakajima; M Imai; T Komatsu; S Sugiura
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.